ATE413882T1 - 2-(phenylthiomethyl)- morpholin-derivate zur verwendung als selektive norepinephrin- wiederaufnahme-inhibitoren - Google Patents
2-(phenylthiomethyl)- morpholin-derivate zur verwendung als selektive norepinephrin- wiederaufnahme-inhibitorenInfo
- Publication number
- ATE413882T1 ATE413882T1 AT03751812T AT03751812T ATE413882T1 AT E413882 T1 ATE413882 T1 AT E413882T1 AT 03751812 T AT03751812 T AT 03751812T AT 03751812 T AT03751812 T AT 03751812T AT E413882 T1 ATE413882 T1 AT E413882T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- inhibitors
- reuppose
- phenylthiomethyl
- morpholine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0219690A GB0219690D0 (en) | 2002-08-23 | 2002-08-23 | Benzyl morpholine derivatives |
US41532802P | 2002-10-01 | 2002-10-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE413882T1 true ATE413882T1 (de) | 2008-11-15 |
Family
ID=31948037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03751812T ATE413882T1 (de) | 2002-08-23 | 2003-08-18 | 2-(phenylthiomethyl)- morpholin-derivate zur verwendung als selektive norepinephrin- wiederaufnahme-inhibitoren |
Country Status (7)
Country | Link |
---|---|
US (1) | US7384941B2 (de) |
EP (1) | EP1534291B1 (de) |
AT (1) | ATE413882T1 (de) |
AU (1) | AU2003269923A1 (de) |
DE (1) | DE60324685D1 (de) |
ES (1) | ES2315525T3 (de) |
WO (1) | WO2004017977A2 (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003055850A1 (fr) | 2001-12-27 | 2003-07-10 | Daiichi Pharmaceutical Co., Ltd. | Inhibiteurs de la production/secretion de la proteine amyloide-$g(b) |
AU2003261245A1 (en) | 2002-08-23 | 2004-03-11 | Eli Lilly And Company | Benzyl morpholine derivatives |
GB0219687D0 (en) * | 2002-08-23 | 2002-10-02 | Lilly Co Eli | Benzyl morpholine derivatives |
PL379466A1 (pl) | 2003-06-30 | 2006-09-18 | Daiichi Sankyo Company , Limited | Heterocykliczne pochodne metylosulfonu |
GB0319793D0 (en) * | 2003-08-22 | 2003-09-24 | Lilly Co Eli | Pyridinylmorpholine derivatives |
JP2007513945A (ja) * | 2003-12-12 | 2007-05-31 | イーライ リリー アンド カンパニー | 体熱感、衝動調節障害および一般的な病状による人格変化の治療 |
DE602004019698D1 (de) | 2003-12-23 | 2009-04-09 | Lilly Co Eli | Morpholinderivate als inhibitoren der wiederaufnahme von norepinephrin |
JP4185154B2 (ja) * | 2004-04-30 | 2008-11-26 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | 中枢神経系障害治療用の置換モルホリン化合物 |
GB0409744D0 (en) * | 2004-04-30 | 2004-06-09 | Pfizer Ltd | Novel compounds |
WO2007005935A2 (en) * | 2005-07-06 | 2007-01-11 | Molecular Neuroimaging, Llc | Norepinephrine transporter radiotracers and methods of syntheses thereof |
JP5405571B2 (ja) * | 2008-07-24 | 2014-02-05 | セラヴァンス, インコーポレーテッド | 3−(フェノキシフェニルメチル)ピロリジン化合物 |
CA2742114C (en) * | 2008-11-14 | 2016-09-13 | Theravance, Inc. | Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound |
JP2012524098A (ja) * | 2009-04-15 | 2012-10-11 | セラヴァンス, インコーポレーテッド | 3−(フェノキシピロリジン−3−イル−メチル)ヘテロアリール、3−(フェニルピロリジン−3−イルメトキシ)ヘテロアリールおよび3−(ヘテロアリールピロリジン−3−イルメトキシ)ヘテロアリール化合物 |
JP5826173B2 (ja) | 2009-07-13 | 2015-12-02 | セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー | 3−フェノキシメチルピロリジン化合物 |
JP5714580B2 (ja) | 2009-07-21 | 2015-05-07 | セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー | 3−フェノキシメチルピロリジン化合物 |
JP5705239B2 (ja) | 2010-01-11 | 2015-04-22 | セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー | セロトニンおよびノルエピネフリン再取込みインヒビターとしての1−(2−フェノキシメチルフェニル)ピペラジン化合物 |
ES2543064T3 (es) * | 2010-03-22 | 2015-08-14 | Theravance Biopharma R&D Ip, Llc | Compuestos de 1-(2-fenoximetilheteroaril)piperidina y piperazina |
CN103153950B (zh) | 2010-10-11 | 2015-11-25 | 施万生物制药研发Ip有限责任公司 | 血清素再摄取抑制剂 |
US8501964B2 (en) | 2010-12-03 | 2013-08-06 | Theravance, Inc. | Serotonin reuptake inhibitors |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE759013R (fr) | 1969-11-17 | 1971-05-17 | Ici Ltd | Derives de la |
GB1412546A (en) | 1973-08-08 | 1975-11-05 | Ici Ltd | Morpholine derivatives |
GB2167407B (en) | 1984-11-22 | 1988-05-11 | Erba Farmitalia | Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof |
US5658590A (en) | 1995-01-11 | 1997-08-19 | Eli Lilly And Company | Treatment of attention-deficit/hyperactivity disorder |
EA000856B1 (ru) | 1995-07-24 | 2000-06-26 | Эли Лилли Энд Компани | Способ лечения синдрома дефицита внимания/гиперактивности |
JP2001517628A (ja) | 1997-09-23 | 2001-10-09 | イーライ・リリー・アンド・カンパニー | 注意欠陥/多動障害の治療法 |
BR9907203A (pt) | 1998-01-21 | 2000-10-17 | Glaxo Group Ltd | "composto, composições farmacêuticas, uso de um composto, e, processo de tratametno de depressão, distúrbio de hiperatividade por deficiência de atenção (adhd), obesidade, enxaqueca, dor, disfunção sexual, doença de parkinson, doença de alzeheimer, ou vìcio de cocaìna ou de produtos contendo nicotina (especialmente tabaco) em um indivìduo animal ou humano. " |
GB9812662D0 (en) | 1998-06-11 | 1998-08-12 | Merck Sharp & Dohme | Therapeutic use |
US6503905B1 (en) | 1998-12-29 | 2003-01-07 | Pfizer Inc | 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
EA004860B1 (ru) | 1999-02-23 | 2004-08-26 | Пфайзер Продактс Инк. | Ингибиторы обратного захвата моноаминов для лечения расстройств цнс |
ATE305307T1 (de) | 1999-07-01 | 2005-10-15 | Pharmacia & Upjohn Co Llc | Reboxetin zur behandlung von migränekopfschmerzen |
-
2003
- 2003-08-18 AT AT03751812T patent/ATE413882T1/de not_active IP Right Cessation
- 2003-08-18 WO PCT/US2003/023269 patent/WO2004017977A2/en not_active Application Discontinuation
- 2003-08-18 EP EP03751812A patent/EP1534291B1/de not_active Expired - Lifetime
- 2003-08-18 AU AU2003269923A patent/AU2003269923A1/en not_active Abandoned
- 2003-08-18 US US10/524,650 patent/US7384941B2/en not_active Expired - Fee Related
- 2003-08-18 ES ES03751812T patent/ES2315525T3/es not_active Expired - Lifetime
- 2003-08-18 DE DE60324685T patent/DE60324685D1/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1534291B1 (de) | 2008-11-12 |
EP1534291A2 (de) | 2005-06-01 |
WO2004017977A3 (en) | 2004-04-01 |
US7384941B2 (en) | 2008-06-10 |
AU2003269923A1 (en) | 2004-03-11 |
WO2004017977A2 (en) | 2004-03-04 |
ES2315525T3 (es) | 2009-04-01 |
US20060035894A1 (en) | 2006-02-16 |
DE60324685D1 (de) | 2008-12-24 |
AU2003269923A8 (en) | 2004-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE413882T1 (de) | 2-(phenylthiomethyl)- morpholin-derivate zur verwendung als selektive norepinephrin- wiederaufnahme-inhibitoren | |
BRPI0413232A (pt) | novos compostos tendo atividade inibitória contra os trasnportadores dependentes de sódio | |
MXPA04001258A (es) | Activador para el receptor d que responde al proliferador de peroxisoma. | |
ATE377004T1 (de) | Proteinkinaseinhibitoren | |
ATE457025T1 (de) | Kinaseinhibitoren | |
EP1642880A4 (de) | Proteininhibitoren der hsp90-familie | |
EA200401172A1 (ru) | Производные n-[фенил(пиперидин-2-ил)метил]бензамида, способ их получения и их применение в терапии | |
PH12015501098A1 (en) | Antituberculous composition comprising oxazole compounds | |
HRP20000406B1 (en) | Arylpiperazines having activity at the serotonin 1a receptor | |
NO20015446D0 (no) | Kinolin-derivater som inhibitorer for MEK-enzymer | |
DE602004020730D1 (de) | Pharmazeutisches verfahren und damit hergestellte verbindungen | |
ATE374750T1 (de) | Serotoninwiederaufnahme-inhibitoren | |
HUP0302961A2 (hu) | (Aminoalkoxibenzoil) benzofuránok vagy benzotiofének, eljárás ilyen vegyületek előállítására és ilyen vegyületeket tartalmazó készítmények | |
EA200800149A1 (ru) | 4,5-диарилпиррольные производные, способ их получения и применение в терапии | |
NO971687D0 (no) | Diazepinoindoler som forsfodiesterase IV-inhibitorer | |
ATE550332T1 (de) | 4-imidazolin-2-onverbindungen als p38-map- kinaseinhibitors | |
EA200101230A1 (ru) | Новые ингибиторы металлопротеаз, метод их получения и содержащие их фармацевтические композиции | |
ATE343566T1 (de) | Propanamine derivate als serotonin und norepinephrin reuptake-inhibitoren | |
ATE239722T1 (de) | Benzofurylpiperazine als serotonin-agonisten | |
DK1628968T3 (da) | 4-imidazolin-2-on-forbindelser | |
EA200200523A1 (ru) | Новые разветвленные замещенные аминопроизводные 3-амино-1-фенил-1h[1,2,4]триазола, способы их получения и содержащие их фармацевтические композиции | |
EA200101050A1 (ru) | Замещенные бензолактамные соединения | |
ATE497497T1 (de) | 1,2,4-triazolderivat, verfahren zu dessenherstellung, und dieses enthaltende pharmazeutische zusammensetzung | |
ATE327982T1 (de) | Benzylmorpholinderivate | |
FI955933A (fi) | Abeo-ergoliinijohdannaiset 5HT1A-ligandeina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |